Pharmaceutical and biotechnology companies, government agencies, key opinion leaders and the investigator community have used our clinical research services and therapeutic expertise to advance the development of effective treatments.
Comprehensive phase I–IV clinical trial services for GI-related research that include unique planning, start-up, initiation, oversight, close-out and reporting for all phases. We are recognized as international leaders in outcomes development, cluster randomization trials and centralized imaging solutions; and we are implicitly trusted by pharmaceutical and biotechnology companies, government agencies, key opinion leaders and the investigator community.
We develop new solutions that improve clinical trial outcomes and accelerate drug development timelines. We were first out with central imaging of endoscopy and histopathology, and our recently built translational science network accelerates and enhances early drug development.